| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.046 | 0.3 |